Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025–2026

Scott et al. (Wed,) studied this question.

www.synapsesocial.com/papers/69de516da051b8e25be93be6 — DOI: https://doi.org/10.1056/nejmsa2514268

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Effectiveness of nirsevimab immunoprophylaxis against respiratory syncytial virus-related outcomes in hospital and primary care settings: a retrospective cohort study in infants in Catalonia (Spain)· 2024 · 90 citations
2. Association between COVID-19 vaccination and stroke: a nationwide case-control study in Qatar· 2024 · 5 citations
3. Cohort study of cardiovascular safety of different COVID-19 vaccination doses among 46 million adults in England· 2024 · 30 citations
4. Risk of Guillain-Barré Syndrome Following COVID-19 Vaccines· 2023 · 25 citations
5. BNT162b2 XBB Vaccine for COVID-19 Among Children 5-17 Years of Age· 2024 · 8 citations